questionText: To ask the Secretary of State for Health and Social Care, what his planned timetable is for the rollout of Durvalumab for the treatment of bladded cancer.
answerText: The National Institute for Health and Care Excellence (NICE) makes recommendations on whether new medicines should be funded by the National Health Service based on their costs and benefits. Wherever possible, NICE aims to align its processes with the reg...
heading: Bladder Cancer: Durvalumab